The U.S. Food and Drug Administration has approved AstraZeneca and partner Daiichi Sankyo's precision drug to treat a type of ...
The US Food and Drug Administration (FDA) has approved datopotamab deruxtecan for the treatment of certain patients with ...
AstraZeneca has overhauled its local management in China, replacing Michael Lai with Alex Lin as the country's general ...
The U.S. government has awarded Moderna $590 million to advance the late-stage development of its mRNA bird flu vaccine, as ...
It’s a sobering statistic: 1 in 8 women in the United States will be diagnosed with breast cancer during her lifetime.1 ...
The new American College of Cardiology expert consensus includes a four-part staging system with a segment for “asymptomatic” ...
AstraZeneca has overhauled its local management in China in a bid to move on from recent scandals and revive sales after the ...
AstraZeneca (AZN) changes key management roles in China as the company emerges from several scandals involving its executives ...
AstraZeneca’s Fasenra, an IL-5-targeting monoclonal antibody already approved for asthma, represents a promising contender ...
AstraZeneca restructures its China operations following leadership scandals and sales challenges, appointing new executives ...
AstraZeneca (AZN) stock in focus as the U.S. FDA expands approval for its lymphoma therapy Calquence with chemoimmunotherapy ...
Health emergencies are on the rise in Africa. Last year, there were 213 public health outbreaks that the pan-African public ...